First CAR-T cell medicine for mantle cell lymphoma approved

The European Medicines Agency has recommended granting a licence for treatment with autologous anti-CD19-transduced CD3+ cell therapy.
The European Medicines Agency has recommended granting a licence for treatment with autologous anti-CD19-transduced CD3+ cell therapy.